Related Experiment Videos
[Fabry's disease in Spain. Study of 24 cases]
Miguel Angel Barba Romero1, Abelardo García de Lorenzo y Mateos,
1Servicio de Medicina Interna, Complejo Hospitalario y Universitario de Albacete, Albacete, Spain. mabarbar@sescam.jccm.es
Medicina Clinica
|July 1, 2004
Summary
Fabry disease, a rare X-linked disorder, presents diverse symptoms in Spanish patients, with males showing angiokeratomas and cardiovascular issues, and females experiencing ophthalmologic and cardiovascular complications. Early diagnosis is crucial for effective Fabry disease management.
Area of Science:
- Genetics and rare diseases
- Metabolic disorders
- Lysosomal storage diseases
Context:
- Fabry disease is an X-linked inherited metabolic disorder caused by alpha-galactosidase A deficiency.
- This enzyme deficiency leads to glycosphingolipid accumulation in cells, causing significant morbidity and mortality.
- Data from the Fabry Outcome Survey (FOS) registry provides insights into patient characteristics.
Purpose:
- To present baseline clinical data of Spanish Fabry disease patients included in the FOS registry.
- To analyze the overall clinical characteristics and gender-specific manifestations.
- To contribute to a better understanding of Fabry disease presentation in Spain.
Summary:
- The study analyzed 24 Spanish Fabry disease patients from the FOS registry.
- Median age of symptom onset was 13 years, with diagnosis at 25.5 years.
- Key manifestations included angiokeratomas, pain, and cardiovascular/kidney involvement in males; ophthalmologic and cardiovascular issues in females.
Impact:
- This study represents the largest Spanish cohort of Fabry disease patients reported to date.
- Recognizing the broad spectrum of Fabry disease symptoms is vital for early diagnosis.
- Timely diagnosis enables the initiation of available specific therapies for Fabry disease.